![Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology | Full Text Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-022-01604-7/MediaObjects/12933_2022_1604_Fig1_HTML.png)
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology | Full Text
![GIP and GLP‐1, the two incretin hormones: Similarities and differences - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library GIP and GLP‐1, the two incretin hormones: Similarities and differences - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/17f97155-8c0a-4d47-98b1-56ef9893b303/jdi_22_f2.gif)
GIP and GLP‐1, the two incretin hormones: Similarities and differences - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library
![Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial - The Lancet Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial - The Lancet](https://www.thelancet.com/cms/attachment/5edca10b-eaf1-4d99-aa22-bc0fe35aeb00/gr1.gif)
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial - The Lancet
![Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0079610711000812-gr2.jpg)
Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect
![The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology | Full Text The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01412-5/MediaObjects/12933_2021_1412_Fig1_HTML.png)
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology | Full Text
![Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes – touchENDOCRINOLOGY Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes – touchENDOCRINOLOGY](https://www.touchendocrinology.com/wp-content/uploads/sites/5/2022/06/Fig-1.png)
Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes – touchENDOCRINOLOGY
![Intracellular actions of GIP and GLP-1 on the-cell. Several cellular... | Download Scientific Diagram Intracellular actions of GIP and GLP-1 on the-cell. Several cellular... | Download Scientific Diagram](https://www.researchgate.net/profile/Michael-Nauck/publication/43351718/figure/fig3/AS:667650296385545@1536191643322/Intracellular-actions-of-GIP-and-GLP-1-on-the-cell-Several-cellular-functions-are.png)
Intracellular actions of GIP and GLP-1 on the-cell. Several cellular... | Download Scientific Diagram
![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/414ba3e0-5948-4dd5-a9ba-672073b1496d/dom14496-fig-0002-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0079610711000812-gr3.jpg)